Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4578-31-8

Post Buying Request

4578-31-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4578-31-8 Usage

Description

Adenosine 5'-monophosphate disodium salt is a modified phosphoramidite used for the synthesis of deoxyribonucleosides and nucleosides. Adenosine 5'-monophosphate disodium salt is an activator of a class of protein kinases known as AMP-activated protein kinase (AMPK). It may be used as a substrate by a variety of enzymes such as AMP-thymidine kinase, AMP deaminase and 5?-nucleotidase.

Chemical Properties

White powder

Uses

Different sources of media describe the Uses of 4578-31-8 differently. You can refer to the following data:
1. Adenosine 5'-monophosphate disodium salt is useful for skin rejuvenation in dermatology and aesthetic dermatology.
2. Adenosine-5'-monophosphate disodium salt is a nucleotide involved in the reactions of cellular energy transfers. It is useful for skin rejuvenation in dermatology and aesthetic dermatology. It acts as an activator of a class of protein kinases called as AMP-activated protein kinase (AMPK). Further, it is used as a substrate for enzymes such as AMP-thymidine kinase, AMP deaminase and 5'-nucleotidase.

Check Digit Verification of cas no

The CAS Registry Mumber 4578-31-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,7 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4578-31:
(6*4)+(5*5)+(4*7)+(3*8)+(2*3)+(1*1)=108
108 % 10 = 8
So 4578-31-8 is a valid CAS Registry Number.

4578-31-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate

1.2 Other means of identification

Product number -
Other names 5′-AMP-Na2

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4578-31-8 SDS

4578-31-8Synthetic route

adenosine
58-61-7

adenosine

A

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

B

adenosine-5'-O-(1-thiophosphate)

adenosine-5'-O-(1-thiophosphate)

Conditions
ConditionsYield
Stage #1: adenosine In various solvent(s) at 20 - 100℃; for 0.333333h;
Stage #2: With 2,6-dimethylpyridine; trichlorophosphate In various solvent(s) at 0℃; for 3h;
A 28%
B 48%
adenosine-5'-O-(1-thiophosphate)

adenosine-5'-O-(1-thiophosphate)

A

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

B

(SP)-O-adenosine-5'-O-(1-thiotriphosphate)

(SP)-O-adenosine-5'-O-(1-thiotriphosphate)

C10H13N5O13P3(3-)*3Na(1+)

C10H13N5O13P3(3-)*3Na(1+)

Conditions
ConditionsYield
With phosphorating extract from S. cerevisiae at 28℃; for 8h;A 8%
B 30.5 mg
C 11%
adenosine
58-61-7

adenosine

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: various solvent(s) / 0.33 h / 20 - 100 °C
1.2: 48 percent / PSCl3; 2,6-lutidine / various solvent(s) / 3 h / 0 °C
2.1: 8 percent / phosphorating extract from S. cerevisiae / 8 h / 28 °C
View Scheme
Acridin-9-yl-[3-(1,13-dioxa-4,7,10,16,19,22-hexaaza-cyclotetracos-7-yl)-propyl]-amine; hydrochloride
117576-36-0

Acridin-9-yl-[3-(1,13-dioxa-4,7,10,16,19,22-hexaaza-cyclotetracos-7-yl)-propyl]-amine; hydrochloride

A

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

B

C32H53N8O5P*3H(1+)

C32H53N8O5P*3H(1+)

Conditions
ConditionsYield
In water; water-d2 at 80℃; Rate constant;
C10H14N6O9P2(2-)*2Na(1+)

C10H14N6O9P2(2-)*2Na(1+)

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Conditions
ConditionsYield
With water; zinc(II) cation pH=5.5;
Diadenosine triphosphate
5959-90-0

Diadenosine triphosphate

bovine serum albumine

bovine serum albumine

A

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

B

adenosine 5'-triphosphate disodium salt

adenosine 5'-triphosphate disodium salt

C

adenosine 5'-diphosphate, disodium salt

adenosine 5'-diphosphate, disodium salt

Conditions
ConditionsYield
With diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) phosphorylase from Mycobacterium tuberculosis H37Rv at 37℃; for 0.5h; pH=7.6; Kinetics; aq. buffer; Enzymatic reaction;
CoN(C3H6NH2)3(OH2)2(3+)
669055-13-4, 96914-54-4

CoN(C3H6NH2)3(OH2)2(3+)

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

{((tris(aminopropyl)amine)Co)2PO4}(ClO4)3

{((tris(aminopropyl)amine)Co)2PO4}(ClO4)3

Conditions
ConditionsYield
In water Kinetics; react. for about 6 h at 25°C;; elem. anal.;100%
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With Dowex 50W×8 resin In water at 20℃; for 0.5h;99%
With Dowex 50WX-8 200 mesh, H+
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

α,β-D-ribofuranose-5-phophate disodium salt
108321-99-9, 150713-51-2

α,β-D-ribofuranose-5-phophate disodium salt

Conditions
ConditionsYield
With Dowex 50 W-X8 (H+ form) In water for 0.141667h; Heating;94%
tetra[μ-acetato-bis(methanol)]dirhodium

tetra[μ-acetato-bis(methanol)]dirhodium

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

A

dirhodium tetracetate dihydrate
917499-87-7, 29998-99-0

dirhodium tetracetate dihydrate

B

tetrakis-μ-acetato-dirhodium(II) adenosine-5'-monophosphate adduct

tetrakis-μ-acetato-dirhodium(II) adenosine-5'-monophosphate adduct

Conditions
ConditionsYield
In water slight excess of nucleotide, stirring for 5 h (dissoln.); pptn. on acetone addn.; elem. anal.;A n/a
B 80%
cysteinato-O-methylester-palladium(II)-μ-dichloro-cysteinato-O-methylester-palladium(II)
71427-90-2

cysteinato-O-methylester-palladium(II)-μ-dichloro-cysteinato-O-methylester-palladium(II)

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

sodium [cysteinato-O-methylester-chloro-adenosine-5'-monophosphate-palladium(II)]

sodium [cysteinato-O-methylester-chloro-adenosine-5'-monophosphate-palladium(II)]

Conditions
ConditionsYield
In water Pd complex and nucleoside suspended in water, stirred at 55°C until complete dissolution; added ethanol, ppt. filtered, washed with 80% ethanol until free from chloride, then with abs. ethanol and ether, dried at 60°C under vac., elem. anal.;50%
4,4'-bipyridine
553-26-4

4,4'-bipyridine

copper(II) nitrate hexahydrate

copper(II) nitrate hexahydrate

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

water
7732-18-5

water

[(copper(II))2(adenosine 5’-monophosphate)2(4,4’-bipyridine)2(H2O)4](nitrate)2*11H2O

[(copper(II))2(adenosine 5’-monophosphate)2(4,4’-bipyridine)2(H2O)4](nitrate)2*11H2O

Conditions
ConditionsYield
Stage #1: 4,4'-bipyridine; copper(II) nitrate hexahydrate; water In ethanol for 0.25h;
Stage #2: adenosine-5'-monophosphate disodium salt In ethanol
Stage #3: With nitric acid In ethanol for 1h; pH=3.65;
49%
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

di-n-butylthioxophosphoranyl bromide
55656-88-7

di-n-butylthioxophosphoranyl bromide

adenosine 5'-phosphoric di-n-butylphosphinothioic anhydride
57816-25-8

adenosine 5'-phosphoric di-n-butylphosphinothioic anhydride

Conditions
ConditionsYield
With pyridine; N,N'-dicyclohexyl-4-morpholine carboxamidine for 3h; Ambient temperature;
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 94 percent / Dowex 50 W-X8 (H+ form) / H2O / 0.14 h / Heating
2: 70 mmol / Na2ATP, MgCl2*6H2O, PEP-K+, K2HPOu, Na2EDTA / 96 h / 30 °C / immobilized PRPP synthetase, pyruvate kinase, adenylate kinase, pH 7.4
3: MgCl2*6H2O, DTT / 192 h / PAN-immobilized O-5-decarboxylase, O-5-P-pyrophosphorylase, PPiase
View Scheme
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

5-phospho-D-ribosyl α-1-pyrophosphate
87372-47-2, 94902-32-6, 108321-05-7, 129136-58-9

5-phospho-D-ribosyl α-1-pyrophosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 94 percent / Dowex 50 W-X8 (H+ form) / H2O / 0.14 h / Heating
2: 70 mmol / Na2ATP, MgCl2*6H2O, PEP-K+, K2HPOu, Na2EDTA / 96 h / 30 °C / immobilized PRPP synthetase, pyruvate kinase, adenylate kinase, pH 7.4
View Scheme
disodium(bis(5-sulfosalicylaldehyde)o-phenylenediiminato)cobaltate(II)

disodium(bis(5-sulfosalicylaldehyde)o-phenylenediiminato)cobaltate(II)

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

disodium[(bis(5-sulfosalicylaldehyde)-o-phenylenediiminato)cobalt(II)]*adenosine-5'-monophosphate disodium salt

disodium[(bis(5-sulfosalicylaldehyde)-o-phenylenediiminato)cobalt(II)]*adenosine-5'-monophosphate disodium salt

Conditions
ConditionsYield
With potassium nitrate In water (N2); mixing cobalt complex and AMP in 0.2 M aq. KNO3 at pH 7.0; not isolated, detected by UV;
Cr(L-Cys)Cl2*2H2O

Cr(L-Cys)Cl2*2H2O

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Cr(5'AMP)(L-Cys)*7H2O

Cr(5'AMP)(L-Cys)*7H2O

Conditions
ConditionsYield
In water addn. of a soln. of Na2(5'AMP) (pH = 4.2) to a soln. of Cr(L-Cys)Cl2*2H2O, 40°C, 3 h, pptn.; filtration, ppt. washed with EtOH, dried in vac. (P4O10), elem. anal.;
Cr(L-Cys)2Cl*2H2O

Cr(L-Cys)2Cl*2H2O

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Cr(5'AMP)(L-Cys)*3H2O

Cr(5'AMP)(L-Cys)*3H2O

Conditions
ConditionsYield
In water addn. of a soln. of Na2(5'AMP) (pH = 7.0) to a soln. of Cr(L-Cys)2Cl*2H2O, the mixture (pH = 5.9) at 40°C, 6 h (final pH = 5.8); concd. to 5 ml, chromy. (Sephadex G-10), evapn., ppt. washed with EtOH, dried in vac. (P4O10), elem. anal.;
cobalt(II) chloride hexahydrate

cobalt(II) chloride hexahydrate

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

cobalt(II) adenosine 5'-monophosphate

cobalt(II) adenosine 5'-monophosphate

Conditions
ConditionsYield
In sodium hydroxide react. at 25°C in triethanoleamine*HCl-NaOH buffer (pH 7.5);
chromium(III) nitrate

chromium(III) nitrate

1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Cr2(5'AMP)3*10H2O

Cr2(5'AMP)3*10H2O

Conditions
ConditionsYield
In water soln. of Cr(NO3)3 and nucleotide were mixed and heated at 50°C for 2 h, soln. of ligand in H2O was added (pH=3.5); filtered, washed, dried over P2O5; elem. anal.;
Cr(L-his)2Cl3*3H2O

Cr(L-his)2Cl3*3H2O

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Cr(5'AMP)(C6H9N3O2)(EtOH)*5H2O

Cr(5'AMP)(C6H9N3O2)(EtOH)*5H2O

Conditions
ConditionsYield
In water mixing a soln. of Cr-complex dissolved in water and Na25'AMP in water (starting pH=5.8), placed in a thermostatic bath at 45°C for 21 h, pptn. with small amount, addn. of EtOH, pptn.; filtration, washed with EtOH, vac. dried over P4O10; elem. anal.;
Cr(L-his)(OH)Cl2*H2O

Cr(L-his)(OH)Cl2*H2O

adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

Cr2(5'AMP)3*10H2O

Cr2(5'AMP)3*10H2O

Conditions
ConditionsYield
In water mixing a soln. of Cr-complex dissolved in water and Na25'AMP in water (pH=3.5-3.6), thermostatic bath at 45°C for 11-16 h; soln concd. (rotavapor), ppt. obtained with 5'AMP before elution, dried over P4O10;

4578-31-8Relevant articles and documents

Structural insights into the novel diadenosine 5′,5?-P 1,P4-tetraphosphate phosphorylase from Mycobacterium tuberculosis H37Rv

Mori, Shigetarou,Shibayama, Keigo,Wachino, Jun-Ichi,Arakawa, Yoshichika

, p. 93 - 104 (2011)

Rv2613c is a diadenosine 5′,5?-P1,P 4-tetraphosphate (Ap4A) phosphorylase from Mycobacterium tuberculosis H37Rv. Sequence analysis suggests that Rv2613c belongs to the histidine triad (HIT) motif superfamily, which includes HIT family diadenosine polyphosphate (ApnA) hydrolases and Ap4A phosphorylases. However, the amino acid sequence of Rv2613c is more similar to that of HIT family ApnA hydrolases than to that of typical Ap4A phosphorylases. Here, we report the crystal structure of Rv2613c, which is the first structure of a protein with ApnA phosphorylase activity, and characterized the structural basis of its catalytic activity. Our results showed that the structure of Rv2613c is similar to those of other HIT superfamily proteins. However, Asn139, Gly146, and Ser147 in the active site of Rv2613c replace the corresponding Gln, Gln, and Thr residues that are normally found in HIT family ApnA hydrolases. Furthermore, analyses of Rv2613c mutants revealed that Asn139, Gly146, and Ser147 are important active-site residues and that Asn139 has a critical role in catalysis. The position of Gly146 might influence the phosphorylase activity. In addition, the tetrameric structure of Rv2613c and the presence of Trp160 might be essential for the formation of the Ap4A binding site. These structural insights into Rv2613c may facilitate the development of novel structure-based inhibitors for treating tuberculosis.

Supported Synthesis of Adenosine Nucleotides and Derivatives on a Benzene-Centered Tripodal Soluble Support

Appy, Lucie,Peyrottes, Suzanne,Roy, Béatrice

, (2021/06/23)

The first soluble-phase synthesis of adenosine nucleotides including α,β and β,γ-methylene bisphosphonate analogues on a multi-pod support is reported. Anchoring of a 2’,3’-protected purine nucleoside to the tripodal support via the nucleobase was successfully achieved using a microwave assisted Cu(I)-catalyzed azide-alkyne cycloaddition. Then, phosphorylation was performed, followed by cleavage with aqueous ammonia to provide adenine derivatives, and finally deprotection. When using benzylamine instead of ammonia, a derivative with N6-benzylamine adenine as nucleobase was obtained. This methodology allows to access adenosine 5’-mono, di and triphosphates, as well as various analogues of pharmacological interest in modest to good yields.

Multiple molecular recognition and catalysis. A multifunctional anion receptor bearing an anion binding site, an intercalating group, and a catalytic site for nucleotide binding and hydrolysis

Hosseini, Mir Wais,Blacker, A. John,Lehn, Jean-Marie

, p. 3896 - 3904 (2007/10/02)

The multifunctional receptor molecule 2 has been designed and synthesized in order to achieve higher molecular recognition and reaction selectivity via multiple interactions with bound substrates. It combines three functional subunits: two recognition sites - a macrocyclic polyammonium moiety as anion binding site and an acridine side-chain for stacking interactions - as well as a catalytic amino group in the macrocycle for facilitating hydrolytic reactions. Compound 2 binds mono- and dinucleotide polyphosphates by simultaneous interactions between its macrocyclic polycationic moiety and the polyphosphate chain as demonstrated by 31P NMR spectroscopy and by stacking between its acridine derivative and the nucleic base of nucleotides as observed by both 1H NMR spectroscopy and by fluorescence spectrophotometry. Binding of nucleotides by protonated 2 induces significant upfield shifts of the polyphosphate signals and of protons of the acridine moiety of 2 as well as of the adenine and the anomeric proton of the nucleotides; at the same time the proton signals corresponding to CH2 groups of the macrocyclic part of 2 are downfield shifted. Upon complexation of ATP and CTP, the fluorescence emission of 2 is enhanced, whereas guanosine triphosphate causes a slight quenching; thus, 2 acts as a sensitive and selective fluorescent probe for ATP. At neutral pH the hydrolytic reaction proceeds, at least in part, through a covalent intermediate, the phosphorylated macrocycle 2 indicating nucleophilic catalysis. Compound 2 shows greater selectivity between ATP and ADP than the parent compound 1 which does not contain the acridine binding site. 2 also binds strongly to DNA plasmid pBR 322 at 10-6 M probably via a double type of interaction, involving both intercalation and electrostatic interactions with the phosphate groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4578-31-8